Details for Patent: 7,897,623
✉ Email this page to a colleague
Summary for Patent: 7,897,623
Title: | .omega.-carboxyl aryl substituted diphenyl ureas as p38 kinase inhibitors |
Abstract: | This invention relates to the use of a group of aryl ureas in treating p38 mediated diseases, and pharmaceutical compositions for use in such therapy. |
Inventor(s): | Riedl; Bernd (Wuppertal, DE), Dumas; Jacques (Carlisle, MA), Khire; Uday R. (Orange, CT), Lowinger; Timothy B. (Carlisle, MA), Scott; William J. (Guilford, CT), Smith; Roger A. (Chester Springs, PA), Wood; Jill E. (Ft. Collins, CO), Monahan; Mary-Katherine (Hamden, CT), Natero; Reina (Hamden, CT), Renick; Joel (Milford, CT), Sibley; Robert N. (North Haven, CT) |
Assignee: | Bayer Healthcare LLC (Tarrytown, NY) |
Application Number: | 11/845,597 |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 7,897,623 |
Patent Claim Types: see list of patent claims | Composition; Compound; Dosage form; |
Drugs Protected by US Patent 7,897,623
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 7,897,623
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Argentina | 035310 | ⤷ Try a Trial | |||
Argentina | 077485 | ⤷ Try a Trial | |||
Austria | 321027 | ⤷ Try a Trial | |||
Austria | 460398 | ⤷ Try a Trial | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |